Gilbert M. Rishton

Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

Edward F. Nemeth, Haynes Heaton, Michael A. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 365 citations

Reactive compounds and in vitro false positives in HTS

Gilbert M. Rishton · Drug Discovery Today · 1997 · 354 citations

Medicine, Bioanalysis, Chemical Pathology +5

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity

Nicholas J. Izzo, Jinbin Xu, Chenbo Zeng et al. · PLoS ONE · 2014 · 292 citations · Full text

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits

Nicholas J. Izzo, Agnes Staniszewski, Lillian K. To et al. · PLoS ONE · 2014 · 185 citations · Full text

Synthetic Abeta Oligomers, Synaptic Signaling, Alzheimer's Disease +18

A crowdsourcing evaluation of the NIH chemical probes

Tudor I. Oprea, Cristian Bologa, Scott Boyer et al. · Nature Chemical Biology · 2009 · 112 citations · Full text

Engineering, Chemical Analysis, Data Science +5